Avermectin B1a
(Synonyms: 阿维菌素B1a; Abamectin B1a) 目录号 : GC14872An anthelmintic and insecticidal agent
Cas No.:65195-55-3
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Avermectin B1a is a modulator of gamma-aminobutyric acid (GABA)-controlled chloride ion channels [1].
Avermectin B1a is a macrocyclic lactone derivative and possesses anthelmintic and insecticidal activities. It was obtained from the fermentation products of Streptomyces avermitilis. Avermectin B1a is usually worked as an anthelmintic and insecticidal agent. It suppresses the signal transmission of nematodes from the central command interneurons to the peripheral motoneurons. The mechanism of this action is that avermectin B1a can enhance the effects of glutamate on the gamma-aminobutyric acid (GABA)-controlled chloride ion channels, causing an influx of chloride ions into the cells. It subsequently leads to hyperpolarisation and subsequent paralysis of the neuromuscular systems. The excitatory effects can be reversed by the chloride ion channel blocker picrotoxin. Since mammals do not have this kind of ion channels, avermectin B1a has no toxicity for mammals [1 and 2].
In rat brain synaptic membranes, avermectin B1a significantly enhanced GABA binding up to 80% over control at concentration of 7 μM. Avermectin B1a also showed protection efficacy for GABA receptors from denaturation when the synaptic membranes were incubated at 60° C with 50 mM Tris-Cl. In the lobster stretcher muscle, treatment of avermectin B1a resulted in the block of IPSPs and the reduction of EPSPs. Besides that, avermectin B1a was found to have promoting effects on benzodiazepine binding. It enhanced flunitrazepan binding to synaptic membranes with EC50 value 50-fold lower than that of GABA [3 and 4].
When given to cattle, the oral administration of avermectin B1a at dose of 0.1 mg/kg reduced more than 95% of T. colubriformis, T. axei, Haemonchus placei, C. oncophora, Cooperia punctate, Ostertagia ostertagi, Oesophagostomum radiatum and Dictyocaulus viviparus. When given to sheep at the same dose, avermectin B1a administration caused also 95% above reduction of Trichostrongylus axei, Haemonchus contortus, Cooperia oncophora, Trichostrongylus colubriformis, Ostertagia circumcincta and Oesophagostomum columbianum [5].
References:
[1] Wang C C, Pong S S. Actions of avermectin B1a on GABA nerves. Progress in clinical and biological research, 1981, 97: 373-395.
[2] Bloomquist J R. Toxicology, mode of action and target site-mediated resistance to insecticides acting on chloride channels. Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology, 1993, 106(2): 301-314.
[3] Pong S S, DeHaven R, Wang C C. A comparative study of avermectin B1a and other modulators of the gamma-aminobutyric acid receptor. chloride ion channel complex. The Journal of Neuroscience, 1982, 2(7): 966-971.
[4] Fritz L C, Wang C C, Gorio A. Avermectin B1a irreversibly blocks postsynaptic potentials at the lobster neuromuscular junction by reducing muscle membrane resistance. Proceedings of the National Academy of Sciences, 1979, 76(4): 2062-2066.
[5] Egerton J R, Ostlind D A, Blair L S, et al. Avermectins, new family of potent anthelmintic agents: efficacy of the B1a component. Antimicrobial Agents and Chemotherapy, 1979, 15(3): 372-378.
Cas No. | 65195-55-3 | SDF | |
别名 | 阿维菌素B1a; Abamectin B1a | ||
Canonical SMILES | CCC(C)C1C(C=CC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C | ||
分子式 | C48H72O14 | 分子量 | 873.08 |
溶解度 | DMSO : 25 mg/mL (28.63 mM; ultrasonic and warming and heat to 60°C) | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 1.1454 mL | 5.7269 mL | 11.4537 mL |
5 mM | 0.2291 mL | 1.1454 mL | 2.2907 mL |
10 mM | 0.1145 mL | 0.5727 mL | 1.1454 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。